Top 10 Books about Stock Investing to read in 2018. Read more.

VTGN - VistaGen Therapeutics Inc

Fri 15'th Jun 2018

PERIOD 2018-03-16 - 2018-06-15
CHANGE 1.35%
PRICE $1.50





Request Prediction

VistaGen Therapeutics Inc Stock Analysis

Technical stock analysis for Fri 15'th Jun 2018

Buy candidate since 2018-06-12 Gain 6.38%

VistaGen Therapeutics Inc gained 1.35% in the last trading day, rising from $1.48 to $1.50 The price has been going up and down for this period, and there has been a 10.29% gain for the last 2 weeks. Volume fell in the last day by -169 452 shares, and in total, 521 037 shares bought and sold for approximately $0.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Shorts 1.36% ( 2018-05-31 )
Cash 16.4 mill
Loans 0.4 mill
Beta 0.40
ROA -139.37


VistaGen Therapeutics Inc lies in the upper part of a very wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $1.54 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 27.15% during the next 3 months and, with 90% probability hold a price between $1.32 and $1.96 at the end of this period.

Click here for today's Top 5 Trending Companies


VistaGen Therapeutics Inc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.45 and $1.18. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday May 29, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 52 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

VistaGen Therapeutics Inc finds support from accumulated volume at $1.49.

Support: $1.49 Price: $1.50


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.11 between high and low, or 7.75%. For the last week the stock has had a daily average volatility of 10.20%.

Our recommended stoploss: $1.42 (-5.41%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 13 days ago.)

Overall risk:

Very Low Low Medium High Very High


VistaGen Therapeutics Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Buy Candidate.

Trade VTGN CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features